Managed Care - March 2008 - (Page M2) SELF-STUDY CONTINUING EDUCATION ACTIVITY Mind Your Body: The Intersection of Physical and Behavioral Health Continuing education credit is offered to physicians and pharmacists who read pages 3 through 26 of this publication, complete the post-test on page 27, and submit the evaluation form on page 28. Estimated time to complete this activity is 2.75 hours. Target audience Medical directors, pharmacy directors, primary care physicians, and health care executives. Purpose and overview This publication is based upon content presented at the 2007 Medical Director Colloquy, held on Dec. 6–7, 2007, in Las Vegas. The Colloquy focused on issues surrounding the link between physical health and behavioral health, which plays a critical role in appropriate patient management. Decision makers in managed care have many critical issues before them, including efficacy, cost, and treatment options, which can effectively improve health outcomes. Topics discussed in this publication include the following patient care issues with regard to physical and mental health: • Health care decision making by the patient and primary care physician • Pay-for-performance initiatives • Community data sharing • Data integration/extraction • Wellness strategies Educational objectives After reading this publication, participants will be able to: • Discuss the link between physical health and behavioral health and the impact on appropriate patient care management • Identify opportunities for health plans and practitioners to collaborate to reduce emergency care services and hospitalizations, and to ensure the appropriate use of diagnostic tests, ambulatory care, and psychotropic medications • Identify solutions to some of the key challenges facing medical directors, pharmacy directors, and other health care professionals Accreditation and designation This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the sponsorship of The Chatham Institute, which is accredited by the ACCME to provide continuing medical education for physicians. The Chatham Institute designates this continuing medical education activity for a maximum of 2.75 AMA PRA Category 1 Credit(s).TM Physicians should claim only those credit hours commensurate with the extent of their participation in the activity. The Chatham Institute is approved by the Accredita® tion Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 2.75 contact hours (0.275 CEU) of continuing education for pharmacists. ACPE universal program number (UPN): 812-000-08-007-H01-P Release Date: Mar. 15, 2008 Expiration Date: Mar. 15, 2009 Medium: Journal Supplement Planning committee members Jeanne L. Alexander, MD, FABPN; Elisabeth J. Buchman, MA, LMHC; Richard G. Frank, PhD; Michael Golinkoff, PhD, MBA; Anthony M. Kotin, MD; Kurt Kroenke, MD; Steven R. Peskin, MD, MBA; Juan C. Prieto, LCSW, CEAP; David A. Shore, PhD; Albert Tzeel, MD, MHSA; David J. Whitehouse, MD, PhD; Audrie Tornow, Education Manager, The Chatham Institute; Michael D. Dalzell, and Katherine T. Adams, editors, MediMedia USA Managed Markets Publishing. Conflict-of-interest policy and disclosures of significant relationships It is the policy of The Chatham Institute to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty members who affect the content of medical education activities sponsored by The Chatham Institute are required to disclose to the audience any real or apparent conflict of interest related to the activity. Faculty members are further required to disclose discussion of off-label uses in their presentations. Any faculty member not complying with the disclosure policy is not permitted to participate in the educational activity. The faculty of this program has disclosed the financial relationships with commercial interests cited below. All program content has been peer reviewed for balance and any potential bias. The process to resolve conflicts of interest aims to ensure that financial relationships with commercial interests and resultant loyalties do not supersede the public interest in the design and delivery of continuing medical education activities for the profession. Kurt Kroenke, MD: Consulting fee and honoraria from Eli Lilly & Co. and Pfizer. Jeanne Leventhal Alexander, MD, FABPN; Elizabeth J. Buchman, MA, LMHC; Richard G. Frank, PhD; Michael Golinkoff, PhD, MBA; Anthony M. Kotin, MD; Steven R. Peskin, MD, MBA; Juan Prieto, LCSW, CEAP; David A. Shore, PhD; Albert Tzeel, MD, MHSA; David J. Whitehouse, MD, PhD; Audrie Tornow; Michael D. Dalzell; and Katherine T. Adams declare they have no financial relationships to disclose. Program sponsorship and support This activity is sponsored by The Chatham Institute and is supported by an educational grant from AstraZeneca Pharmaceuticals LP. 2 MANAGED CARE / SUPPLEMENT
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.